NDC 50090-5960-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5960
- Requested NDC
- 50090-5960-01
- Package NDCs from labels
- 50090-5960-0, 50090-5960-2, 50090-5960-1, 50090-5960-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2024-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5960-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 50090-5960-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 50090-5960-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5960 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240511_1bb08103-04ee-47a6-a9ad-290e169feb51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5960-0 | EA - Each | 50090-5960 | 236055f1-416d-4476-9b0a-73e1e0487b4e | 1 | 2022-07-06 |
| 50090-5960-1 | EA - Each | 50090-5960 | 7d68ca49-dafa-447b-a05c-8d0bc0a3e141 | 1 | 2022-07-06 |
| 50090-5960-2 | EA - Each | 50090-5960 | 4e10ae2d-dd32-475b-9ed6-a7938f3dac25 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUN BUFF SPF 30 MINERAL SUNSCREEN | ZINC OXIDE/TITANIUM DIOXIDE | SPF Ventures, LLC | 3f874062-ebab-8993-e063-6294a90abfc5 | 2025-09-24 | Warnings | 15FIX9V2JP |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Marlex Pharmaceuticals, Inc. | df881501-42ae-624a-e053-2995a90ab2a0 | 2025-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | bbf7e20d-dfc2-4115-8788-c0cac15a1148 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 979468 979471 979464 3ST302B24A 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 4d7a0e82-4791-4e3f-932a-2f1a2993ba36 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 45d0b1cc-d88d-4044-9692-c143cdf7a1b8 | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 0c728db3-86ae-4ed9-b86a-78ff8d18876a | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| ERBORIAN CC RED CORRECT | ERBORIAN CC RED CORRECT SPF 25- OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE CREAM | Kolmask Co., Ld. | 09ca2d4b-e0c2-9961-e063-6394a90aa82e | 2025-09-18 | 15FIX9V2JP | |
| ELROEL Pang Pang Sun Cushion Plus | ZINC OXIDE, TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | MONOGLOT HOLDINGS Inc. | 5ffaad65-f0b2-416a-b0a3-b92e880641e4 | 2025-09-18 | Warnings | 15FIX9V2JP |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | Bryant Ranch Prepack | eace2965-c02b-49ec-aad8-3a69a6ae9cbf | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| CVS SPF 50 Face Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | CVS | 26a69a47-947a-a478-e063-6394a90aa468 | 2025-09-16 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ba2c08b-5ce5-4967-bc3b-2c73df9865af | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | ec6dce85-5c0b-475c-af0b-cbbc034f698f | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 60f3f17d-fd28-406d-97ca-9f01f5f1c72c | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | 979468 3ST302B24A 0J48LPH2TH |
| Losartan potassium Tablets, 50 mg | LOSARTAN POTASSIUM | Bryant Ranch Prepack | eea03814-3fb5-4f85-8a4d-18e73057d880 | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| sunscreen | TITANIUM DIOXIDE(NANO) | Mingyu (guangdong) Cosmetics Technology Co., Ltd | 3e6fe9f3-486b-bba7-e063-6294a90adf37 | 2025-09-10 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dbb07e2-971c-284d-e063-6294a90a437f | 2025-09-06 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6 | ENSULIZOLE,HOMOSALATE ,OCTINOXATE ,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3e069cb2-c4c5-abf5-e063-6394a90a56b0 | 2025-09-06 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NorthStar Rx LLC | 25318baf-9c2f-458f-b9ea-f52dabca49af | 2025-09-06 | Boxed warning, Warnings, Adverse reactions | 979468 979471 979464 3ST302B24A 0J48LPH2TH |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.